3 completed. 2 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 1 | Completed 1 |
Follow ALZ-801: new trials by email Literature Review of ALZ-801 trials Research Report on ALZ-801
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Biomarker Effects of ALZ-801 in APOE4 Carriers With Early Alzheimer's Disease ALZ-801 - Early Alzheimer's Disease | Phase 2 | Completed | Alzheon Inc. | 84 | 2020-09-30 | 2025-12-18 |
| Multiple Ascending Dose Study of ALZ-801 ALZ-801 or matching placebo - Alzheimer Disease | Phase 1 | Completed | Alzheon Inc. | 48 | 2015-09-26 | 2019-11-19 |
| Single Dose Study of ALZ-801 Prototype Tablets ALZ-801 170 mg Fasting, ALZ-801 205 mg Fasting, ALZ-801 205 mg After Food - Alzheimer Disease | Phase 1 | Completed | Alzheon Inc. | 12 | 2015-09-16 | 2020-10-14 |
Alzheon Inc. (3)
Czechia (1) · Netherlands (1) · United Kingdom (1)
Ann Church, PhD (1) · John Hey, PhD (1) · Pui Leung, MD (1)
PMID 29063518, PMID 38902571, PMID 38902572, PMID 39907966, PMID 42678603